Resources and funding

Zarah Ali (not her real name) remembers how things changed for the better. “In 2014, I received a loan of 40 000 Djiboutian francs (US$ 250) that I used to develop and improve my garment business. I was also trained in business entrepreneurship, including marketing and customer satisfaction. I import clothes from Dubai and Somaliland and earn a decent income that helps me support my 25-year-old son, my 16-year-old daughter in secondary school and my three-year-old adopted son. I am able to pay for my rent, electricity and water and have decent meals.”

Ms Ali’s loan came from an income-generation programme established by the World Food Programme in collaboration with the United Nations Development Programme, UNAIDS and the national network of people living with HIV in Djibouti (RNDP+). The programme supports the long-term empowerment of, and provides regular incomes to, women living with HIV in Djibouti City. It helps them to achieve financial security and have access to food and improves their access to health-care services. Income-generating activities such as those supported by the programme have a powerful potential to help people living with HIV adhere to antiretroviral therapy and optimize health outcomes. 

The loans, ranging from US$ 141 to US$ 438 per person, are for starting or building retail businesses. The beneficiaries, who are selected from among two networks of people living with HIV affiliated to RNDP+ (ARREY and Oui à la Vie – Yes to Life), also receive training on how to run their business. Government support in the form of favourable policies and legislation has been vital to the success of the programme. 

Dekah Mohammed (not her real name) now lives a fulfilling life after receiving help from the income-generation programme. Ms Mohammed, who lost her husband to AIDS, lives with six children. After she lost her job in the hospitality sector owing to her deteriorating health and to stigma and discrimination, she started her own clothing business and received a loan of 50 000 Djiboutian francs (US$ 313) to expand her business. The loan was repaid within 10 months. Her business has since expanded into furniture and electronics and she has recruited an employee. “I am no longer a desperate woman. I make enough to take care of my family and dependants,” she said. 

The programme has improved the quality of life of many Djiboutian women, allowing them to regain dignity and ensure their financial security. It empowers women and girls to protect themselves from HIV, make decisions about their health, live free from violence and be financially independent. 

Building on the belief that empowering women living with HIV and their households to be financially independent strengthens adherence to treatment and leads to more fulfilling and dignified lives, the programme contributes to the World Food Programme’s broader strategic contribution towards ending AIDS as a public health threat by 2030.

U.S. remains top donor, providing more than half the total

GENEVA/UNITED STATES, 16 July 2019—Donor government disbursements to combat HIV in low- and middle-income countries totaled US$8 billion in 2018, little changed from the US$8.1 billion total in 2017 and from the levels of a decade ago, finds a new report from the Kaiser Family Foundation (KFF) and the Joint United Nations Programme on HIV/AIDS (UNAIDS).

Half of the 14 donor governments analyzed in the study increased their spending on global HIV efforts from 2017 to 2018; five decreased their spending; and two held steady. Donor government funding supports HIV care and treatment, prevention and other services in low- and middle-income countries.

The United States remains the world’s largest donor for HIV by far, disbursing US$5.8 billion last year, and also ranks first in disbursements relative to the size of each donor’s economy. The next largest donors are the United Kingdom (US$605 million), France (US$302 million), the Netherlands (US$232 million) and Germany (US$162 million).

Since 2010, donor governments, other than the United States, significantly reduced their funding for HIV, which fell by more than $1 billion in the aftermath of the global financial crisis, and with the competing aid demands of a global refugee crisis and other humanitarian challenges. Most of the decline was in bilateral support. 

These donors increased their support for the Global Fund to Fight AIDS, Tuberculosis and Malaria over this period, but not by enough to offset a large drop in bilateral support. When factoring how the Global Fund divides its resources among the three diseases, and reduced funding for UNITAID, multilateral support for HIV has also fallen since 2010.

The data on donor government funding for HIV feed into the broader UNAIDS report Communities at the Centre, which examines all sources of funding for HIV relief, including local governments, non-governmental organizations and the private sector, and compares it to need. According to estimates from that report, there was a decline of $1 billion across all sources of funding between 2017 and 2018, leaving a $7 billion gap between resources and need in 2020 after adjusting for inflation.

“Donor contributions are vital for the AIDS response, particularly in East and South African countries, except South Africa, where the majority of countries rely on donors for 80% of their HIV responses," said Gunilla Carlsson, Executive Director a.i., UNAIDS. "It is disconcerting that in 2018, total available resources for HIV declined by US$ 1 billion. I call on all countries—domestic and donors to urgently increase their investments and close the US$ 7 billion funding gap for the AIDS response.”

“Since the global financial crisis a decade ago, donor governments’ support for HIV has flattened and funding from donors other than the U.S., which has held steady, has gone down,” said KFF Senior Vice President Jen Kates. “Unless this calculus changes, efforts to prevent and treat HIV globally will need to rely increasingly on other sources of funding."

The new report, produced as a long-standing partnership between KFF and UNAIDS, provides the latest data available on donor government funding based on data provided by governments. It includes their bilateral assistance to low- and middle-income countries and contributions to the Global Fund as well as UNITAID.  “Donor government funding” refers to disbursements, or payments, made by donors.

The Kaiser Family Foundation

KFF is a non-profit organization focusing on national health issues, as well as the U.S. role in global health policy.

UNAIDS

The Joint United Nations Programme on HIV/AIDS (UNAIDS) leads and inspires the world to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths. UNAIDS unites the efforts of 11 UN organizations—UNHCR, UNICEF, WFP, UNDP, UNFPA, UNODC, UN Women, ILO, UNESCO, WHO and the World Bank—and works closely with global and national partners towards ending the AIDS epidemic by 2030 as part of the Sustainable Development Goals. Learn more at unaids.org and connect with us on Facebook, Twitter, Instagram and YouTube.

GENEVA, 27 June 2019—UNAIDS and the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) have signed a strategic framework for cooperation and collaboration to strengthen and accelerate support to countries’ efforts to end AIDS. The framework outlines the existing, wide-ranging scope of collaboration between the two organizations, and highlights specific areas for enhanced cooperation to help focus efforts and resources where they are needed most.

“The long-standing partnership between UNAIDS and the Global Fund has been instrumental in helping countries to halt and reverse their HIV epidemics,” said Gunilla Carlsson, UNAIDS Executive Director, a.i. “The new framework builds on this successful partnership and will deliver maximum impact for people on the ground, enhance country ownership and sustainability, and Fast-Track progress towards ending AIDS.”

Under the new framework, UNAIDS and the Global Fund will advocate for a more robust response to HIV, support each other’s activities and processes, and continue to provide strategic information, technical support and capacity building to countries. The two organizations will advocate for increased global and domestic funding, work to improve data collection and systems and ensure data is used strategically for decision making and implementation.

“Partnership is in the Global Fund’s DNA, and we will continue to work closely with UNAIDS to step up the fight against HIV and save millions of lives,” said Peter Sands, Executive Director of the Global Fund.

The framework highlights critical areas for enhanced collaboration which include HIV prevention and treatment access, community-led service delivery, gender, rights and community engagement and a special focus on accelerating progress in West and Central Africa. To measure progress towards the enhanced areas for collaboration a results matrix will be established.

UNAIDS will continue to analyse gaps in the response to HIV, support the development of national strategic plans and investment cases and address human rights and gender-related barriers to equitable access to health services. UNAIDS will also ensure that civil society are fully engaged in the response to HIV, particularly communities and key populations most affected by HIV.

The Global Fund will continue to attract, leverage and invest additional resources to end HIV. The Global Fund currently raises and invests nearly US$ 4 billion a year for the responses to HIV, tuberculosis and malaria, to support programmes run by local experts and leaders in countries and communities most in need.

UNAIDS urges donors to fully fund the Global Fund to Fight AIDS, Tuberculosis and Malaria at its sixth replenishment conference taking place in France in October 2019. This will enable countries, civil society and partners to implement an evidence-informed, people-centred and human-rights based response to HIV.

UNAIDS

The Joint United Nations Programme on HIV/AIDS (UNAIDS) leads and inspires the world to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths. UNAIDS unites the efforts of 11 UN organizations—UNHCR, UNICEF, WFP, UNDP, UNFPA, UNODC, UN Women, ILO, UNESCO, WHO and the World Bank—and works closely with global and national partners towards ending the AIDS epidemic by 2030 as part of the Sustainable Development Goals. Learn more at unaids.org and connect with us on Facebook, Twitter, Instagram and YouTube.

Ukraine has announced that it is to allocate $16 million to the country’s AIDS response for 2019-20, which will sustain and expand HIV prevention and support services for key populations as well as care and support services for people living with HIV.

The procurement of HIV services for key populations and people living with HIV from suppliers, including non-governmental organizations, will be managed by the Ministry of Health’s Centre for Public Health, using public procurement procedures. The new process will begin in July.

The move is an important part of Ukraine’s transition from donor funding to a nationally funded AIDS response.  

"Ukraine has taken an important step towards moving from international funding to a nationally coordinated policy and ownership,” said Vladimir Kurpita, director of the Centre for Public Health at the Ministry of Health.

The list of services covered by the new policy includes targeted HIV information services and consultations, harm reduction programmes, including needle exchange and distribution, the distribution of condoms and lubricants, HIV testing and screening for tuberculosis. Key populations prioritized include gay men and other men who have sex with men, sex workers, and people who inject drugs. HIV care and support services include strengthening treatment adherence and retention under medical supervision and the involvement of partners of people living with HIV in health care services.

Mr Kurpita promised a smooth transition and said that the government would procure quality-assured services from local non-governmental organizations with the relevant experience and capacity to deliver.

“Nobody who was reached through prevention, support and care services that were funded by external donors should ever be cut off from the transition to government support,” he said.

The head of the All Ukrainian Network of People Living with HIV, 100% Life, Dima Sherembey, encouraged everyone to engage in the process.

"If you are an NGO service provider, engage in bidding; if you are a representative of the donor community in Ukraine, motivate your partners and subcontractors on the ground; and if you have resources and knowledge, provide technical support and assistance to bidders so that they can be successful recipients and implementers of this important wave of government funding,” he said.

UNAIDS country director Roman Gailevich welcomed Ukraine’s commitment to increase domestic funding for the AIDS response.

“We are entering a new era of the national response to HIV in Ukraine,” he said. “We hope Ukraine will not only show that this new model of procurement of HIV services is viable, but that it will also serve as an example to other countries in the region.”

Leaders from both the private and public sectors have called for fresh investment models for new technologies and the smarter roll-out of innovations to end AIDS and tuberculosis by 2030.

The plea was made by panellists taking part in a debate at the Health Innovation Exchange, a three-day event organized by UNAIDS and held between 21 and 23 May on the sidelines of the World Health Assembly in Geneva, Switzerland.

Speaking at the event, the Executive Director of the Stop TB Partnership, Lucica Ditiu, said new approaches are vital in order to make faster progress in the response to the epidemics.

“We will not achieve our targets of ending AIDS and tuberculosis by doing things as we have always done them in the past,” she said. “Products must be developed with the patient in mind and we must work with developers to help them gather evidence that their innovations work in order to shorten the timeline from validation to implementation.”

Roland Göhde, chair of the German Healthcare Partnership, a joint venture of the Government of Germany and the Federation of German Industries, said there was an urgent need for greater synergies right along the chain of development and innovation. “The private sector needs to be systemically involved by other sectors. We need to bundle and conflate the different expertise of the involved sectors to get rid of fragmentation.” 

Mr Göhde also underlined the importance of training in new technologies. He described how the German Healthcare Partnership had facilitated the training of laboratory workers in Burkina Faso in new haematology technologies as well as the training of biomedical engineers in Kenya and Senegal.

Jenifer Healy from USAID reminded the audience that the World Health Organization had estimated that the cost of achieving the Sustainable Development Goals health targets was an initial US$ 134 billion annually in 2017, rising to US$ 371 billion by 2030.

“While we have made great progress in global health, including in reducing the impact of AIDS, the funding gap for new investments will triple by 2030,” she said.

The Global Head of Public Health at Johnson & Johnson, Jaak Peeters, also underlined the importance of supporting the best science possible for global health, a more rapid implementation of best practice innovation and the fullest embrace of public–private collaboration.

In his comments, the Director-General of the Ghana Health Service, Anthony Nsiah-Asare, said that political commitment was required to ensure that innovation was deployed to deliver smarter, more efficient and high-quality services to the people most in need.

Low- and middle-income countries (LMICs) are becoming increasingly interested in developing the local production of quality-assured medicines and other health technologies. This is due to its potential to assist LMICs in improving access to quality-assured medicines and other health technologies, achieving universal health coverage (UHC), and reaching the health-related targets and broader developmental objectives of the Sustainable Development Goals. 

The term "Local Production" can be defined in various ways. For the purposes of this statement, "local" refers to the geographical location, i.e. occurring in the country or region, and "production" — in regard to pharmaceuticals for example — refers to all activities along the pharmaceutical manufacturing value chain. Within the context of the public health agenda, promoting local production requires a holistic approach that considers policy coherence, regulatory systems strengthening, access to finance for sustainable production, a careful assessment of the business case, development of skilled human resources, access to technology for production and needs-based innovation, creation of investment incentives and other factors, to enable manufacturers to comply with international quality standards, be competitive and engage in sustainable manufacturing. 

The Global Strategy and Plan of Action on Public Health Innovation and Intellectual Property, adopted at the 61st World Health Assembly (WHA) in 2008, cites local production and related transfer of technology as one of the elements to promote innovation, build capacity and improve access. More recently, at the 71st WHA in May 2018, Member States highlighted the importance of local production in the context of the global shortage of, and access to, medicines and vaccines. 

A number of international organizations have also expressed their desire to source quality-assured medical products closer to the point of use. The pull effect of significant market opportunities can be a major factor in driving progress, particularly when aligned with partnerships in supporting the development of the industry and health workforce. 

Strengthening local production is a cross-cutting endeavour. Sustainable local production requires effective multisectoral collaboration in order to promote enabling investment, legal and technical environments. In many LMICs, the capacity of both local manufacturers to produce and supply quality medical products and the national regulatory authority to ensure quality, efficacy and safety is insufficient. Any supply of medical products — both through local production and imports — should go hand in hand with the strengthening of regulatory capacities in order to achieve compliance with international GxP[1] and other quality standards. Close partnership between the international community and LMICs is essential to support countries and regions to build the capacities, institutions and industries that can sustain the progress made. 

With the globalization of the pharmaceutical industry and the variety of country contexts, there is no "one-size fits-­all" approach in promoting local production of quality-assured medicines and other health technologies. However, in recognition of the important role local production can play in improving access to quality-assured medical products and achieving UHC, the undersigned organizations aim to work in a collaborative, strategic and holistic manner in partnership with governments and other relevant stakeholders to strengthen local production. We are committed to contribute based on our respective organizations' expertise and mandate.

Launched in Geneva on 24 May 2019

Dr Tedros Adhanom Ghebreyesus, Director-General, WHO

Mr Li Yong, Director-General, UNIDO

Dr Mukhisa Kituyi, Secretary-General, UNCTAD

Ms Gunilla Carlsson, Executive Director, a.i., UNAIDS

Ms Henrietta H. Fore, Executive Director, UNICEF

Mr Peter Sands, Executive Director, The Global Fund

[1] Good manufacturing practices, good clinical practices, etc. ^

UNAIDS

The Joint United Nations Programme on HIV/AIDS (UNAIDS) leads and inspires the world to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths. UNAIDS unites the efforts of 11 UN organizations—UNHCR, UNICEF, WFP, UNDP, UNFPA, UNODC, UN Women, ILO, UNESCO, WHO and the World Bank—and works closely with global and national partners towards ending the AIDS epidemic by 2030 as part of the Sustainable Development Goals. Learn more at unaids.org and connect with us on Facebook, Twitter, Instagram and YouTube.

“The fact that something is hard to evaluate doesn’t make it impossible,” said Anna Downie, who leads on strategic information at Frontline AIDS. Reflecting on the challenge of evaluating advocacy, coalition-building, generating new partnerships and increasing the capacity of communities, she added, “To be successful, it is essential to allow space for innovation, to hear from communities about what is important to them and involve them from the outset so that you are looking for the same results and the evaluation is truly useful.”

Ms Downie was one of a number of experts who gathered in UNAIDS headquarters on 29 March in Geneva, Switzerland, for UNAIDS’ first consultation on evaluation. With the aim of informing the new UNAIDS evaluation policy, to be presented to the UNAIDS Programme Coordinating Board (PCB) meeting in June, the participants shared lessons they have learned while working on evaluation.

“Generating evaluations that are independent, credible and useful is the foundation of our work” said Susanne Frueh, the Chair of the United Nations Evaluation Group and Chair of the consultation.

The central role of countries in supporting a strong and independent evaluation function at UNAIDS was highlighted. The need for dedicated funding for evaluation, for the evaluation function to be independent and for transparency in the appointment of the head of the evaluation function were highlighted. The credibility and expertise of the staff of the office of evaluation, the establishment of an independent advisory committee and the need to protect the office from becoming politicized were also noted.

Michel Sidibé, UNAIDS Executive Director, highlighted the importance of the evaluation function. “We will not be able to transform or sustain our gains in the AIDS response if we don’t have clear learning from what we are doing. We will not be able to quicken the pace of action and help countries to scale up if we are not able to share our work and lessons learned,” he said.

The participants agreed that it is essential not only to ensure a strong gender and equity element in evaluations but also to measure what works and identify results in the areas of gender and human rights, which are cornerstones of the AIDS response. Triangulating data on human rights with civil society is a good way of ensuring that the evaluation provides a full picture. The importance of assessing the support provided by UNAIDS when major donors transition from countries was also highlighted.

In the medium to long term, the participants highlighted the need to build the capacity of young evaluators and to consider working with the growing number of evaluation companies from the global South.

The UNAIDS policy on evaluation is to receive a final round of comments from stakeholders soon. It will then undergo a peer review by the United Nations Evaluation Group before being presented to the UNAIDS PCB for endorsement. 

Thirty minutes before the workshop had even started, the meeting room was full. A murmur of voices echoed around the room as the participants took a last look at the data that would be used in the next round of HIV estimate modelling. It was important to get this right—the results of the workshop would eventually influence the allocation of billions of United States dollars-worth of investments in the AIDS response.

More than 100 people from 11 countries in eastern and southern Africa, supported by nine organizations, had come together in Johannesburg, South Africa, to analyse the trends and burden of the HIV epidemic in their countries. The UNAIDS workshop was one of 11 held worldwide between 28 January and 30 March 2019 during which 140 country teams—including epidemiologists, HIV programme managers and monitoring and evaluation experts—learned about the latest updates to the software used to estimate the number of people living with HIV, new HIV infections and AIDS-related deaths.

Over the course of the workshops, the teams produced new estimates on the HIV epidemics in their countries from 1970 to 2018, refining estimates made in past years. Country programmes and donor responses are based on the latest and most accurate data. Such data are used to set targets, identify hotspots, revise national programmes and decide the course of the AIDS response.

Before they arrive at the workshop, the country teams collect programme and surveillance data from their health information systems. At the workshop, those data are entered into Spectrum—a sophisticated UNAIDS-supported computer software package used to compile and analyse data on the HIV epidemic—to produce country HIV estimates.

Those countries that have good facility-level data use that information, together with data on road networks, population densities and other variables, to calculate the number of people living with HIV by district—information that is crucially important for a location–population approach to the AIDS response. Those district estimates are further broken down into different age groups and by sex.

Countries that receive funds from the United States of America import their estimates into a spreadsheet known as the Data Pack, which is used in the process to determine the level of financial support a country will receive.

One country whose AIDS response is supported by the United States is Lesotho. Assigned to support the country team members during the Johannesburg meeting was John Stover, the lead developer of Spectrum, who has an exceptional ability to explain complex concepts and find rigorous solutions even where few data exist.

The Lesotho country team members were eager to develop a comprehensive plan as part of Lesotho’s bid for additional funding, but they were concerned about the new estimates of child HIV infections, which were higher than their previous estimates. Mr Stover worked with the team over the course of the week to walk them through each of the assumptions made in the models, explaining how the model matched the data available from the country and the recent Lesotho Population-Based HIV Impact Assessment (LEPHIA) results and what caused the change in the estimates. A new tool has been included in Spectrum that shows where the new child infections came from and how to strengthen the prevention of mother-to-child HIV transmission programme to reduce the number of new child HIV infections in the future. When they left the workshop, the team had the capacity to explain the new estimates to policy-makers in Lesotho and beyond and to propose how to lower those new HIV infections in the future.

Additional workshops that trained more than 500 people on the Spectrum software have been held around the world, including in: Bangkok, Thailand; Panama City, Panama; Marrakesh, Morocco; Dakar, Senegal; Stockholm, Sweden; and Port of Spain, Trinidad and Tobago. The workshops were supported by facilitators from 14 organizations.

The estimates produced in the workshops will be reviewed by staff at UNAIDS over the coming month for quality assurance, before being signed off by ministers of health and published by UNAIDS at aidsinfo.unaids.org and in a UNAIDS report in mid-2019.

The Desert AIDS Project has awarded its prestigious Science and Medicine Award to UNAIDS. The award was presented to the Deputy Executive Director, Management and Governance, of UNAIDS, Gunilla Carlsson, at the 25th Annual Steve Chase Humanitarian Awards in Palm Springs, United States of America, on 9 February.

“UNAIDS is deeply humbled to receive the Science and Medicine Award from an organization like Desert AIDS Project, which has made, and continues to make, such an incredible contribution to the AIDS response. We accept this award on behalf of all people working to ensure that no one is left behind or excluded from life-saving HIV services,” said Ms Carlsson.

Ms Carlsson was joined on stage by Musah Lumumba El-nasoor, the Team Leader of the East and Southern Africa Youth Alliance on Sexual and Reproductive Health and HIV.

“UNAIDS is mobilizing political support, setting the pace and the global agenda, to ensure that science is matched with the necessary resources and tools to deliver results for all people, including those at the margins of society,” Mr El-nasoor said.

Named after one of the Desert AIDS Project’s earliest financial supporters, the designer Steve Chase, the Steve Chase Humanitarian Awards ceremony is the biggest fundraising event of the year for the Desert AIDS Project and an important event on the Palm Springs social calendar.

Steve Chase died of an AIDS-related illness in 1994 at the age of 52 and left an incredible mark on the Desert AIDS Project through his philanthropic work and his ability to bring people together. The first Steve Chase Awards ceremony was held in his honour in 1995.

The Desert AIDS Project provides HIV prevention, treatment and care services to people living with and affected by HIV across the Palm Springs area. Established by a group of volunteers in 1984, the project is today raising funds to expand its Palm Springs campus. With the support of volunteers and donors, it is hoped that the newly raised funds will help meet the health-care needs of 10 000 people, many who are living with HIV.

The event was attended by around 2000 people and made more than US$ 1 million, which will be put towards the US$ 20 million needed for the Desert AIDS Project’s expansion plans. To date, the Desert AIDS Project has raised US$ 13 million towards its goal.

“With leadership provided by the United Nations, and specifically UNAIDS, all of us, including the Desert AIDS Project, working together will achieve what was previously thought of as impossible: the end of AIDS,” said David Brinkman, the Chief Executive Officer of the Desert AIDS Project.

Past award winners of the Science and Medicine Award include Michael Gottlieb, Desmond Tutu and Anthony Fauci. 

The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) presented its Sixth Replenishment Investment Case to donors and partners at a meeting held in New Delhi, India, on 8 February. The Investment Case calls for US$ 14 billion to be invested over three years to help save 16 million lives through programmes for HIV, tuberculosis and malaria.

The Global Fund estimates that investing today will cut the mortality rate for the three diseases in half and build stronger health systems by 2023. Full funding would enable the Global Fund to continue playing a critical role in the response to HIV, tuberculosis and malaria, accelerating progress towards universal health coverage and achieving the Sustainable Development Goals.

“Only with a fully funded Global Fund to Fight AIDS, Tuberculosis and Malaria can we reach the global targets set for HIV, tuberculosis and malaria,” said Tim Martineau, Deputy Executive Director of UNAIDS, Programme, ai. “UNAIDS is committed to continuing to work with the Global Fund to ensure that it meets its financial targets so that countries can end AIDS as a global health threat and save more lives.”

The Global Fund’s Sixth Replenishment target of US$ 14 billion represents an increase of US$ 1.8 billion, or 15%, more than the US$ 12.2 billion raised during the Fifth Replenishment period.

UNAIDS will continue to strengthen its long-established partnership with the Global Fund to maximize the impact of the investments, accelerate inclusive people-centred responses and end AIDS as public health threat by 2030.

UNAIDS estimates that US$ 26.2 billion will be required for the AIDS response in 2020. In 2017, US$ 21.3 billion was available for the AIDS response in low- and middle-income countries, a shortfall of US$ 5 billion. UNAIDS urges both donors and funding from domestic sources to be scaled up to fill the gaps and end the HIV, tuberculosis and malaria epidemics by 2030 as part of Sustainable Development Goal 3.

Together, UNAIDS and the Global Fund have ensured that millions of people living with HIV have access to treatment and that the people most affected by the epidemic have the health and support services they need.